loadpatents
name:-0.033676147460938
name:-0.020743846893311
name:-0.009260892868042
Alessi; Thomas R. Patent Filings

Alessi; Thomas R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Alessi; Thomas R..The latest application filed is for "rapid establishment and/or termination of substantial steady-state drug delivery".

Company Profile
9.23.30
  • Alessi; Thomas R. - Hayward CA
  • Alessi; Thomas R - Hayward CA
  • Alessi; Thomas R. - Middlesex County NJ
  • Alessi; Thomas R. - Monmouth Junction NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Suspension formulation comprising an insulinotropic peptide
Grant 11,246,913 - Alessi , et al. February 15, 2
2022-02-15
Rapid Establishment And/or Termination Of Substantial Steady-state Drug Delivery
App 20210236413 - Alessi; Thomas R. ;   et al.
2021-08-05
THERAPEUTIC METHODS FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS FOR PATIENTS WITH HIGH BASELINE HbA1c
App 20200397690 - Alessi; Thomas R. ;   et al.
2020-12-24
Rapid establishment and/or termination of substantial steady-state drug delivery
Grant 10,869,830 - Alessi , et al. December 22, 2
2020-12-22
THERAPEUTIC METHODS FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS FOR PATIENTS WITH HIGH BASELINE HbA1c
App 20200360267 - Alessi; Thomas R. ;   et al.
2020-11-19
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
Grant 10,583,080 - Alessi , et al.
2020-03-10
Method Of Manufacturing An Osmotic Delivery Device
App 20200054717 - Alessi; Thomas R. ;   et al.
2020-02-20
Osmotic delivery systems and piston assemblies for use therein
Grant 10,527,170 - Alessi , et al. J
2020-01-07
Devices, formulations, and methods for delivery of multiple beneficial agents
Grant 10,441,528 - Alessi , et al. Oc
2019-10-15
Method of manufacturing an osmotic delivery device
Grant 10,363,287 - Alessi , et al.
2019-07-30
Rapid Establishment And/or Termination Of Substantial Steady-state Drug Delivery
App 20190105259 - Alessi; Thomas R. ;   et al.
2019-04-11
Rapid establishment and/or termination of substantial steady-state drug delivery
Grant 10,231,923 - Alessi , et al.
2019-03-19
Devices, Formulations, And Methods For Delivery Of Multiple Beneficial Agents
App 20180256492 - Alessi; Thomas R. ;   et al.
2018-09-13
THERAPEUTIC METHODS FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS FOR PATIENTS WITH HIGH BASELINE HbA1c
App 20180256491 - Alessi; Thomas R. ;   et al.
2018-09-13
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
Grant 9,889,085 - Alessi , et al. February 13, 2
2018-02-13
Osmotic Delivery Device Comprising An Insulinotropic Peptide And Uses Thereof
App 20170368145 - Alessi; Thomas R ;   et al.
2017-12-28
Osmotic delivery device comprising an insulinotropic peptide and uses thereof
Grant 9,682,127 - Alessi , et al. June 20, 2
2017-06-20
Highly Concentrated Drug Particles, Formulations, Suspensions And Uses Thereof
App 20170119854 - Alessi; Thomas R. ;   et al.
2017-05-04
Devices, Formulations, And Methods For Delivery Of Multiple Beneficial Agents
App 20170079906 - ALESSI; Thomas R. ;   et al.
2017-03-23
Osmotic Delivery Device Comprising An Insulinotropic Peptide And Uses Thereof
App 20170072022 - Alessi; Thomas R. ;   et al.
2017-03-16
Devices, formulations, and methods for delivery of multiple beneficial agents
Grant 9,572,889 - Alessi , et al. February 21, 2
2017-02-21
Rapid Establishment And/or Termination Of Substantial Steady-state Drug Delivery
App 20160354305 - Alessi; Thomas R. ;   et al.
2016-12-08
Highly Concentrated Drug Particles, Formulations, Suspensions And Uses Thereof
App 20160022582 - ALESSI; Thomas R. ;   et al.
2016-01-28
Osmotic Delivery Device Comprising An Insulinotropic Peptide And Uses Thereof
App 20150258016 - Alessi; Thomas R. ;   et al.
2015-09-17
Devices, Formulations, And Methods For Delivery Of Multiple Beneficial Agents
App 20150111818 - Alessi; Thomas R. ;   et al.
2015-04-23
Osmotic delivery comprising an insulinotropic peptide and uses thereof
Grant 8,940,316 - Alessi , et al. January 27, 2
2015-01-27
Devices, formulations, and methods for delivery of multiple beneficial agents
Grant 8,926,595 - Alessi , et al. January 6, 2
2015-01-06
Osmotic Delivery Systems and Piston Assemblies for Use Therein
App 20140378900 - Alessi; Thomas R. ;   et al.
2014-12-25
Osmotic delivery systems and piston assemblies for use therein
Grant 8,801,700 - Alessi , et al. August 12, 2
2014-08-12
Devices, Formulations, and Methods for Delivery of Multiple Beneficial Agents
App 20130090287 - Alessi; Thomas R. ;   et al.
2013-04-11
Rapid Establishment and/or Termination of Substantial Steady-State Drug Delivery
App 20130030417 - Alessi; Thomas R. ;   et al.
2013-01-31
Devices, formulations, and methods for delivery of multiple beneficial agents
Grant 8,343,140 - Alessi , et al. January 1, 2
2013-01-01
Highly Concentrated Drug Particles, Formulations, Suspensions And Uses Thereof
App 20120289944 - Alessi; Thomas R. ;   et al.
2012-11-15
Rapid establishment and/or termination of substantial steady-state drug delivery
Grant 8,298,561 - Alessi , et al. October 30, 2
2012-10-30
Suspension formulations of insulinotropic peptides and uses thereof
Grant 8,299,025 - Alessi , et al. October 30, 2
2012-10-30
Suspension formulations of insulinotropic peptides and uses thereof
App 20120178687 - Alessi; Thomas R. ;   et al.
2012-07-12
Osmotic delivery systems and piston assemblies for use therein
App 20110166554 - Alessi; Thomas R. ;   et al.
2011-07-07
Rapid establishment and/or termination of substantial steady-state drug delivery
App 20110076317 - Alessi; Thomas R. ;   et al.
2011-03-31
Osmotic delivery systems and piston assemblies for use therein
Grant 7,879,028 - Alessi , et al. February 1, 2
2011-02-01
Osmotic delivery systems and piston assemblies for use therein
App 20100185184 - Alessi; Thomas R. ;   et al.
2010-07-22
Highly concentrated drug particles, formulations, suspensions and uses thereof
App 20100092566 - Alessi; Thomas R. ;   et al.
2010-04-15
Osmotic delivery systems and piston assemblies for use therein
Grant 7,682,356 - Alessi , et al. March 23, 2
2010-03-23
Devices, formulations, and methods for delivery of multiple beneficial agents
App 20090202608 - Alessi; Thomas R. ;   et al.
2009-08-13
Suspension formulations of insulinotropic peptides and uses thereof
App 20080260840 - Alessi; Thomas R. ;   et al.
2008-10-23
Osmotic delivery systems and piston assemblies for use therein
App 20080091176 - Alessi; Thomas R. ;   et al.
2008-04-17
Method of mitigating the adverse effects of IL-2
App 20040242676 - Alessi, Thomas R. ;   et al.
2004-12-02
Novel naphthalenylalkyl-3H-1,2,3,5-oxathiadiazole 2-oxides useful as antihyperglycemic agents
Grant 4,897,405 - Alessi , et al. January 30, 1
1990-01-30
Novel benzyl-3H-1,2,3,5-oxathiadiazole 2-oxides useful as antihyperglycemic agents
Grant 4,895,862 - Alessi , et al. January 23, 1
1990-01-23
Company Registrations
SEC0001320382Alessi Thomas R

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed